Empolmin 500 mg (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Daewon Biotech Co., Ltd.
MFDS item code 201906286 · Approved 2019.09.04 · Insurance code 057600160
This product's status changed to Approval withdrawn on 2026.01.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of type 2 diabetes mellitus
This medication is used for the treatment of patients with type 2 diabetes whose blood sugar control is insufficient with dietary and exercise therapy. It is particularly beneficial for overweight diabetes patients. In adult patients, this medication can be used alone or in combination with other oral hypoglycemic agents or insulin. Additionally, children over 10 years and adolescents in growth can use this medication alone or in combination with insulin for treatment. This medication is effective in improving blood sugar control.
The dose should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and determine the minimum dose required for adequate glycemic control. Take 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. If taking more than 2000mg, divide the dose into 3 doses daily and take with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the response to this medicine and determine the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled with diet alone, a short course of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with stage 3a moderate renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dosage adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.
This medication may cause severe lactic acidosis or hypoglycemia, so caution is required. It should not be administered to patients with moderate to severe renal impairment or acute conditions such as dehydration, serious infections, cardiovascular collapse, acute myocardial infarction, or sepsis. It cannot be used in patients with acute and unstable heart failure, and should be discontinued before and after tests that involve intravenous administration of iodinated contrast agents. It is not administered to patients with hypersensitivity to this medication or biguanide medications, type 1 diabetes patients, acute or chronic metabolic acidosis patients, or patients in diabetic pre-coma. In patients with severe infections or severe traumatic systemic disorders, administration should be temporarily discontinued and resumed after the patient’s condition has recovered. In the case of surgery, administration should be stopped 48 hours prior to the procedure, and resumed only after normal kidney function has been confirmed. It should be used with caution in patients who are malnourished, in a state of starvation, frail, have pituitary dysfunction, or adrenal insufficiency. Avoid administration in patients with liver dysfunction, pulmonary embolism, severe pulmonary dysfunction, excessive alcohol consumption, dehydration, gastrointestinal disorders such as diarrhea and vomiting. It should not be administered to pregnant women with placental dysfunction, pre-eclampsia, or risk of delayed intrauterine growth. Since it contains lactose, do not use it in patients with galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Use cautiously in patients with irregular meals, inadequate food intake, intense muscle activity, or taking drug interactions. Lactic acidosis is rare but can be fatal; if symptoms occur, discontinue immediately and consult a healthcare professional. Gastrointestinal symptoms may be common at the start of treatment and can be alleviated by taking with food or gradually increasing the dosage. Metallic taste, rash, anemia, vitamin B12 deficiency, abnormal liver function, hypoglycemia, and other adverse reactions may occur, requiring caution. Kidney function should be monitored regularly, especially in the elderly or those with reduced kidney function. Alcohol can affect lactate metabolism, so excessive drinking should be avoided during treatment with this medication. Blood sugar control is important during pregnancy, and the decision to administer should be made carefully based on the pregnant woman's condition. This medication is secreted into breast milk; careful judgment should be made regarding whether to continue breastfeeding or discontinue drug therapy. Dose adjustments and caution are necessary for children and the elderly, especially with kidney function monitoring being crucial in the elderly. This medication can interact with other drugs, so inform healthcare professionals about any other medications being taken. In case of overdose, blood dialysis can remove the drug, so inform healthcare, if overdose is suspected. This medication does not cause weight gain, making it advantageous for diabetic patients needing weight control.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is also best to store it at room temperature that is not too hot or too cold.
White round film-coated tablets
300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Daewon Biotech Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.